Q3 2024
Released Feb 8, 2024, after the close
10-Q filed Feb 8, 2024, 39 days after period end · 0001516513-24-000009
Q3 2024 · 10-Q
Revenue$135.28M$135.28M +17.4% vs Q3 2023+19.1% vs Q2 2024
Net Income$47.96M$47.96M +43.3% vs Q3 2023+56.7% vs Q2 2024
EPS Diluted$0.24$0.24 +50.0% vs Q3 2023+60.0% vs Q2 2024
Gross Profit$123,094,000+21.0%
Operating Income$58,551,000+52.1%
Operating Cash Flowderived$50,054,000+2.8%
Free Cash Flowderived$50,018,000+3.1%
Margins · derived
Gross margin91.0%+2.7 pt vs Q3 2023
Operating margin43.3%+9.9 pt vs Q3 2023
Net margin35.4%+6.4 pt vs Q3 2023
What the release said
The release
Same quarter
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $135.28M | $115.26M | $97.88M | $58.71M |
| Net Income | $47.96M | $33.47M | $55.65M | $17.23M |
| EPS Diluted | $0.24 | $0.16 | $0.26 | $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Doximity, Inc. · CIK 1516513 · Engraved from SEC EDGAR